A statistical model that incorporates results from the latest population studies may help men and their physicians decide whether the benefits of annual prostate-specific antigen testing outweigh the negatives in their individual cases, according to a report in the Sept. 28 issue of the Archives of Internal Medicine. "Physicians who want to support their patients in this decision can use the information to provide estimates of the likely outcomes (particularly the risk of a screening-detected cancer...